Sartans are a group of pharmaceuticals that modulate the renin- angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Sartans industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan
Market Segment by Product Application
Hypertension
Cardiovascular Diseases
Kidney Diseases
Others
Finally, the report provides detailed profile and data information analysis of leading company.
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Sartans consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Sartans market by identifying its various subsegments.
3.Focuses on the key global Sartans manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Sartans with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Sartans submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Sartans Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Sartans Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Sartans Segment by Type
2.1.1 Valsartan
2.1.2 Telmisartan
2.1.3 Losartan
2.1.4 Irbesartan
2.1.5 Azilsartan
2.1.6 Olmesartan
2.2 Market Analysis by Application
2.2.1 Hypertension
2.2.2 Cardiovascular Diseases
2.2.3 Kidney Diseases
2.2.4 Others
2.3 Global Sartans Market Comparison by Regions (2017-2027)
2.3.1 Global Sartans Market Size (2017-2027)
2.3.2 North America Sartans Status and Prospect (2017-2027)
2.3.3 Europe Sartans Status and Prospect (2017-2027)
2.3.4 China Sartans Status and Prospect (2017-2027)
2.3.5 Japan Sartans Status and Prospect (2017-2027)
2.3.6 Southeast Asia Sartans Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Sartans Industry Impact
2.5.1 Sartans Business Impact Assessment - Covid-19
2.5.2 Market Trends and Sartans Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Sartans Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Sartans Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Sartans Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Sartans Manufacturer Market Share
3.5 Top 10 Sartans Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Sartans Market
3.7 Key Manufacturers Sartans Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Sartans Industry Key Manufacturers
4.1 Pfizer
4.1.1 Compan Detail
4.1.2 Pfizer Sartans Product Introduction, Application and Specification
4.1.3 Pfizer 160 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Pfizer News
4.2 Novartis
4.2.1 Compan Detail
4.2.2 Novartis Sartans Product Introduction, Application and Specification
4.2.3 Novartis Sartans Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Pfizer News
4.3 Merck
4.3.1 Compan Detail
4.3.2 Merck Sartans Product Introduction, Application and Specification
4.3.3 Merck Sartans Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Merck News
4.4 Astra Zeneca
4.4.1 Compan Detail
4.4.2 Astra Zeneca Sartans Product Introduction, Application and Specification
4.4.3 Astra Zeneca Sartans Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Astra Zeneca News
4.5 Jhonson and Johnson
4.5.1 Compan Detail
4.5.2 Astra Zeneca Sartans Product Introduction, Application and Specification
4.5.3 Jhonson and Johnson Sartans Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Jhonson and Johnson News
4.6 Eli Lilly
4.6.1 Compan Detail
4.6.2 Eli Lilly Sartans Product Introduction, Application and Specification
4.6.3 Eli Lilly Sartans Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Eli Lilly News
4.7 Sanofi
4.7.1 Compan Detail
4.7.2 Sanofi Sartans Product Introduction, Application and Specification
4.7.3 Sanofi Sartans Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Bristol-Myers Squibb
4.8.1 Compan Detail
4.8.2 Bristol-Myers Squibb Sartans Product Introduction, Application and Specification
4.8.3 Bristol-Myers Squibb Sartans Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Bristol-Myers Squibb News
4.9 Bayer
4.9.1 Compan Detail
4.9.2 Bayer Sartans Product Introduction, Application and Specification
4.9.3 Bayer Sartans Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Bayer News
4.10 GSK
4.10.1 Compan Detail
4.10.2 GSK Sartans Product Introduction, Application and Specification
4.10.3 GSK Sartans Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 GSK News
4.11 Teva Pharmaceutical
4.11.1 Compan Detail
4.11.2 Teva Pharmaceutical Sartans Product Introduction, Application and Specification
4.11.3 Teva Pharmaceutical Sartans Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Teva Pharmaceutical News
5 Global Sartans Market Segment by Big Type
5.1 Global Sartans Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Sartans Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Sartans Revenue and Market Share by Big Type (2017-2022)
5.2 Valsartan Sales Growth Rate and Price
5.2.1 Global Valsartan Sales Growth Rate (2017-2022)
5.2.2 Global Valsartan Price (2017-2022)
5.3 Telmisartan Sales Growth Rate and Price
5.3.1 Global Telmisartan Sales Growth Rate (2017-2022)
5.3.2 Global Telmisartan Price (2017-2022)
5.4 Losartan Sales Growth Rate and Price
5.4.1 Global Losartan Sales Growth Rate (2017-2022)
5.4.2 Global Losartan Price (2017-2022)
5.5 Irbesartan Sales Growth Rate and Price
5.5.1 Global Irbesartan Sales Growth Rate (2017-2022)
5.5.2 Global Irbesartan Price (2017-2022)
5.6 Azilsartan Sales Growth Rate and Price
5.6.1 Global Azilsartan Sales Growth Rate (2017-2022)
5.6.2 Global Azilsartan Price (2017-2022)
5.7 Olmesartan Sales Growth Rate and Price
5.7.1 Global Olmesartan Sales Growth Rate (2017-2022)
5.7.2 Global Olmesartan Price (2017-2022)
6 Global Sartans Market Segment by Big Application
6.1 Global Sartans Sales Market Share by Big Application (2017-2022)
6.2 Hypertension Sales Growth Rate (2017-2022)
6.3 Cardiovascular Diseases Sales Growth Rate (2017-2022)
6.4 Kidney Diseases Sales Growth Rate (2017-2022)
6.5 Others Sales Growth Rate (2017-2022)
7 Global Sartans Forecast
7.1 Global Sartans Revenue, Sales and Growth Rate (2022-2027)
7.2 Sartans Market Forecast by Regions (2022-2027)
7.2.1 North America Sartans Market Forecast (2022-2027)
7.2.2 Europe Sartans Market Forecast (2022-2027)
7.2.3 China Sartans Market Forecast (2022-2027)
7.2.4 Japan Sartans Market Forecast (2022-2027)
7.2.5 Southeast Asia Sartans Market Forecast (2022-2027)
7.2.6 Other Regions Sartans Market Forecast (2022-2027)
7.3 Sartans Market Forecast by Type (2022-2027)
7.3.1 Global Sartans Sales Forecast by Type (2022-2027)
7.3.2 Global Sartans Market Share Forecast by Type (2022-2027)
7.4 Sartans Market Forecast by Application (2022-2027)
7.4.1 Global Sartans Sales Forecast by Application (2022-2027)
7.4.2 Global Sartans Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Sartans Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Sartans Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Sartans
Figure Market Concentration Ratio and Market Maturity Analysis of Sartans
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Sartans Market Size by Big Type
Figure Global Market Share of Sartans by Big Type in 2021
Figure Valsartan Picture (2017-2022)
Figure Telmisartan Picture (2017-2022)
Figure Losartan Picture (2017-2022)
Figure Irbesartan Picture (2017-2022)
Figure Azilsartan Picture (2017-2022)
Global Sartans Market Size by Big Application
Table Global Sartans Market Size by Application
Figure Global Sartans Market Share by Big Application in 2021
Figure Hypertension Picture
Figure Cardiovascular Diseases Picture
Figure Kidney Diseases Picture
Figure Others Picture
Table Global Sartans Comparison by Regions (M USD) ?2017-2027?
Figure Global Sartans Market Size (Million US$) (2017-2027)
Figure North America Sartans Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Sartans Revenue (Million US$) Growth Rate (2017-2027)
Figure China Sartans Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Sartans Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Sartans Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Sartans Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Sartans Sales by Manufacturer (2017-2022)
Figure Global Sartans Sales Market Share by Manufacturer in 2021
Table Global Sartans Revenue by Manufacturer (2017-2022)
Figure Global Sartans Revenue Market Share by Manufacturer in 2021
Table Global Sartans Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Sartans Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Sartans Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Sartans Market
Table Key Manufacturers Sartans Product Type
Table Mergers & Acquisitions Planning
Table Pfizer Company Profile
Table Sartans Product Introduction, Application and Specification of Pfizer
Table Sartans Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Novartis Company Profile
Table Sartans Product Introduction, Application and Specification of Novartis
Table Sartans Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis Recent Development
Table Merck Company Profile
Table Sartans Product Introduction, Application and Specification of Merck
Table Sartans Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck Main Business
Table Merck Recent Development
Table Astra Zeneca Company Profile
Table Sartans Product Introduction, Application and Specification of Astra Zeneca
Table Sartans Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Astra Zeneca Main Business
Table Astra Zeneca Recent Development
Table Astra Zeneca Main Business
Table Astra Zeneca Recent Development
Table Jhonson and Johnson Company Profile
Table Sartans Product Introduction, Application and Specification of Jhonson and Johnson
Table Sartans Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Jhonson and Johnson Main Business
Table Jhonson and Johnson Recent Development
Table Eli Lilly Company Profile
Table Sartans Product Introduction, Application and Specification of Eli Lilly
Table Sartans Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Eli Lilly Main Business
Table Eli Lilly Recent Development
Table Sanofi Company Profile
Table Sartans Product Introduction, Application and Specification of Sanofi
Table Sartans Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sanofi Main Business
Table Sanofi Recent Development
Table Bristol-Myers Squibb Company Profile
Table Sartans Product Introduction, Application and Specification of Bristol-Myers Squibb
Table Sartans Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bristol-Myers Squibb Main Business
Table Bristol-Myers Squibb Recent Development
Table Bayer Company Profile
Table Sartans Product Introduction, Application and Specification of Bayer
Table Sartans Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bayer Main Business
Table Bayer Recent Development
Table GSK Company Profile
Table Sartans Product Introduction, Application and Specification of GSK
Table Sartans Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table GSK Main Business
Table GSK Recent Development
Table Teva Pharmaceutical Company Profile
Table Sartans Product Introduction, Application and Specification of Teva Pharmaceutical
Table Sartans Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Teva Pharmaceutical Main Business
Table Teva Pharmaceutical Recent Development
Figure Global Sartans Sales and Growth Rate (2017-2022)
Figure Global Sartans Revenue and Growth Rate (2017-2022)
Table Global Sartans Sales by Regions (2017-2022)
Figure Global Sartans Sales Market Share by Regions in 2021
Table Global Sartans Revenue by Regions (2017-2022)
Figure Global Sartans Revenue Market Share by Regions in 2021
Figure North America Sartans Sales and Growth Rate (2017-2022)
Figure Europe Sartans Sales and Growth Rate (2017-2022)
Figure China Sartans Sales and Growth Rate (2017-2022)
Figure Japan Sartans Sales and Growth Rate (2017-2022)
Figure Southeast Asia Sartans Sales and Growth Rate (2017-2022)
Figure Other Regions Sartans Sales and Growth Rate (2017-2022)
Table Global Sartans Sales by Big Type (2017-2022)
Table Global Sartans Sales Market Share by Big Type (2017-2022)
Figure Global Sartans Sales Market Share by Big Type in 2019
Table Global Sartans Revenue by Big Type (2017-2022)
Table Global Sartans Revenue Market Share by Big Type (2017-2022)
Table Global Sartans Revenue Market Share by Big Type in 2019
Figure Global Valsartan Sales Growth Rate (2017-2022)
Figure Global Valsartan Price (2017-2022)
Figure Global Telmisartan Sales Growth Rate (2017-2022)
Figure Global Telmisartan Price (2017-2022)
Figure Global Losartan Sales Growth Rate (2017-2022)
Figure Global Losartan Price (2017-2022)
Figure Global Irbesartan Sales Growth Rate (2017-2022)
Figure Global Irbesartan Price (2017-2022)
Figure Global Olmesartan Sales Growth Rate (2017-2022)
Table Global Sartans Sales by Big Application (2017-2022)
Table Global Sartans Sales Market Share by Big Application (2017-2022)
Figure Global Sartans Sales Market Share by Big Application in 2019
Figure Global Hypertension Sales Growth Rate (2017-2022)
Figure Global Cardiovascular Diseases Sales Growth Rate (2017-2022)
Figure Global Kidney Diseases Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Sartans Sales and Growth Rate (2022-2027)
Figure Global Sartans Revenue and Growth Rate (2022-2027)
Table Global Sartans Sales Forecast by Regions (2022-2027)
Table Global Sartans Market Share Forecast by Regions (2022-2027)
Figure North America Sales Sartans Market Forecast (2022-2027)
Figure Europe Sales Sartans Market Forecast (2022-2027)
Figure China Sales Sartans Market Forecast (2022-2027)
Figure Japan Sales Sartans Market Forecast (2022-2027)
Figure Southeast Asia Sales Sartans Market Forecast (2022-2027)
Figure Other Regions Sales Sartans Market Forecast (2022-2027)
Table Global Sartans Sales Forecast by Type (2022-2027)
Table Global Sartans Market Share Forecast by Type (2022-2027)
Table Global Sartans Sales Forecast by Application (2022-2027)
Table Global Sartans Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sartans
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Sartans Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Sartans Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Sartans Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Sartans Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Sartans Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Sartans Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Sartans Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Sartans Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)